Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$1.66 - $2.31 $880,683 - $1.23 Million
530,532 Added 249.73%
742,972 $1.65 Million
Q2 2023

Aug 04, 2023

SELL
$1.61 - $1.96 $60,400 - $73,531
-37,516 Reduced 15.01%
212,440 $395,000
Q1 2023

May 08, 2023

BUY
$1.8 - $2.83 $449,920 - $707,375
249,956 New
249,956 $484,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.